Company Filing History:
Years Active: 2020-2022
Title: Linda Wicker - Innovator in Immunology
Introduction
Linda Wicker is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of immunology, particularly through her innovative work on fusion proteins. With a total of 3 patents to her name, Wicker's inventions have the potential to impact therapeutic approaches for various diseases.
Latest Patents
Wicker's latest patents focus on interleukin-2 fusion proteins and their uses. The first patent describes fusion proteins of immunoglobulins and interleukin-2 (IL-2). This invention relates to polynucleotides encoding such fusion proteins, as well as vectors and host cells that comprise these polynucleotides. Furthermore, it outlines methods for producing these fusion proteins and their application in disease treatment. The second patent also centers on interleukin-2 fusion proteins, specifically concerning fusion proteins of immunoglobulins and mutant IL-2 that exhibit enhanced properties for therapeutic use. This includes applications in treating autoimmune diseases and immune-mediated inflammatory diseases.
Career Highlights
Throughout her career, Linda Wicker has worked with notable companies such as Roche Glycart AG and Hoffmann-La Roche Inc. Her experience in these organizations has contributed to her expertise in the field of immunology and the development of innovative therapeutic solutions.
Collaborations
Wicker has collaborated with esteemed colleagues, including Ralf Hosse and Christian Klein. These partnerships have likely enriched her research and development efforts, fostering a collaborative environment for innovation.
Conclusion
Linda Wicker's contributions to immunology through her patents on interleukin-2 fusion proteins highlight her role as a leading inventor in the field. Her work continues to pave the way for advancements in therapeutic treatments.